Peter Wan

PhD student in Oncology @OxfordOncology

[Richard Baugh @RichardBaugh3]

Delighted to share our new manuscript published this week in @JITC showcasing a novel oncolytic herpes simplex virus armed to express a Bi-specific T cell Engager which targets NKG2D ligands in glioblastoma.

@Oncolytics_oxon
@OxfordOncology
@BRUKresearch

[Peter Wan @wktpeter]

My latest review has been published in @jitcancer! Can't wait for you all to check it out and share your thoughts. @Oncolytics_oxon @OxfordOncology @OxfordCancer

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC review: Oncolytic viruses and antibodies: are they more successful when delivered separately or when engineered as a single agent? https://t.co/jWDtZx9Frl @wktpeter @theRafLab

[Seymour Lab Oxford @Oncolytics_oxon]

Look out for a poster today presented by one of our talented PhD students @wktpeter on his work using Bispecific T cell Engagers for cancer immunotherapy at P-183 #BSI21 (2/4)

[Oxford Cancer @OxfordCancer]

If you are an @OUHospitals clinician, @UniofOxford staff or student that works in cancer research, diagnosis or treatment - then join our membership

Join the community & contribute to a world where cancers are diagnosed earlier & treated more effectively
https://t.co/oKYuavVCeE

[Seymour Lab Oxford @Oncolytics_oxon]

A fantastic new review from our lab in @jitcancer highlighting the importance of HLA loss when considering immunotherapy in patients. There is an increasing need for predictive biomarkers for selection of patients who will receive such therapies. https://t.co/dyuOLI6auQ

[Peter Wan @wktpeter]

Thank you @OxfordOncology for organising the wonderful symposium. I had a great time presenting my work!

[Seymour Lab Oxford @Oncolytics_oxon]

Congratulations to @wktpeter from our lab who just won best presentation today at the Oxford University Student Symposium. His work has huge potential and was extremely well presented.

[Seymour Lab Oxford @Oncolytics_oxon]

Some of the very talented DPhil students in our lab presenting their work at the annual symposium. They have worked incredibly hard this year and have made some fantastic progress!

[Seymour Lab Oxford @Oncolytics_oxon]

Pleased to announce another new publication from our lab by a very talented PhD student reviewing current strategies to target the tumour microenvironment to tackle cancer https://t.co/WKxVjonGAV

[Oxford Cancer @OxfordCancer]

How can viruses help us to fight #cancer?

@Oncolytics_oxon lab have a new paper investigating the use of a herpes #virus to deliver immunotherapy treatment and kill tumour cells! The video below shows it working (cancer death in green)

Read more here: https://t.co/lPtT8RfBgO

[Seymour Lab Oxford @Oncolytics_oxon]

Thrilled with our latest publication. We use an oncolytic herpes to express a bispecific antibody, activating T cells, generating an inflammatory response and killing cancer & tumour supporting cells. With support from @CRUKOxford and @OxfordOncology https://t.co/pE1YjABXAi